Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Doxorubicin, Ifosfamide, and Irinotecan for Advanced Soft Tissue and Recurrent Bone Sarcomas
NCT00544778Phase 2Terminated
- Sponsor
- City of Hope
- Start
- Aug 2001
- Primary completion
- Nov 2011
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of doxorubicin, ifosfamide, irinotecan in soft tissue sarcoma (STS), bone sarcoma, sponsored by City of Hope. Started Aug 2001; status: terminated.
02
Drugs
doxorubicinifosfamideirinotecan
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT00544778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544778.